Previous Page  37 / 116 Next Page
Information
Show Menu
Previous Page 37 / 116 Next Page
Page Background

Toxicidad BRIM-3

Chapman PB,

et al.

N Engl J Med 2011

Vemurafenib

(N=336)

Dacarbazina

(N=282)

Artralgia (%)

Grado 2

Grado 3

18

3

<1

<1

Rash (%)

Grado 2

Grado 3

10

8

0

0

Astenia (%)

Grado 2

Grado 3

11

2

12

2

Carcinomas epidermoides (%)

Grado 3

12

<1

Keratoacantomas (%)

Grado 2

Grado 3

2

6

0

0

Náuseas (%)

Grado 2

Grado 3

7

1

11

2

Alopecia (%)

Grado 2

8

0

MEK1/2

ERK

P

P

BRAF

V600

MAPK signaling

MEK1/2

ERK

P

P

BRAF

V600

BRAFi

MAPK signaling

CRAF

MEK1/2

ERK

P

P

BRAF

MAPK signaling

RAS

CRAF

MEK1/2

ERK

P

P

BRAF

BRAFi

MAPK signaling

HRAS

Q61

CRAF

CRAF

BRAF

V600 Mutant Melanoma

BRAF

Wild-Type Cells

Holderfield M, Br J Cancer 2014